Medicare Enrolled

Dr. Jesus Hernandez, M.D.

Optician · Sugar Land, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
7616 BRANFORD PL STE 320, Sugar Land, TX 77479
2819801742
In practice since 2006 (19 years)
NPI: 1437183910 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hernandez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hernandez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hernandez

Dr. Jesus Hernandez is an optician in Sugar Land, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hernandez performed 51,739 Medicare services across 616 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hernandez received a total of $251,006 from 50 pharmaceutical and/or device companies across 1540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hernandez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in TX$ $251,006 industry payments

Medicare Practice Summary

Medicare Utilization ↗
51,739
Medicare services
Top 1% in TX for optician
616
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,723 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)27,201$4$20
Abatacept infusion (Orencia)11,895$33$75
Golimumab infusion (Simponi Aria)8,150$11$50
Infliximab infusion (Remicade)2,090$26$200
Denosumab injection (Prolia/Xgeva)781$18$45
Office visit, established patient (30-39 min)619$86$296
Administration of chemotherapy into vein, 1 hour or less275$101$425
Physical therapy exercise, per 15 min207$17$97
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle156$57$255
Steroid injection (triamcinolone)145$1$16
Administration of chemotherapy into vein, each additional hour60$22$110
Injection of additional new drug or substance into vein59$12$55
Injection, methylprednisolone sodium succinate, up to 40 mg35$3$6
New patient office visit (45-59 min)34$116$380
Aspiration and/or injection of fluid large joint using ultrasound guidance20$59$345
Ultrasonic guidance for needle placement12$46$350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.8% high complexity
55.5% medium
1.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$251,006
Total received (2018-2024)
Avg $35,858/year across 7 years
Top 2% in TX for optician
50
Companies
1,540
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$229,974 (91.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,529 (6.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,503 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,124
2023
$16,093
2022
$33,360
2021
$11,684
2020
$32,379
2019
$79,672
2018
$71,693

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$64,679
AbbVie, Inc.
$58,378
Lilly USA, LLC
$53,110
Amgen Inc.
$30,890
AstraZeneca Pharmaceuticals LP
$13,183
AbbVie Inc.
$7,635
Janssen Biotech, Inc.
$5,521
Mallinckrodt Hospital Products Inc.
$4,642
UCB, Inc.
$2,417
ABBVIE INC.
$1,608
E.R. Squibb & Sons, L.L.C.
$1,558
PFIZER INC.
$1,554
Novartis Pharmaceuticals Corporation
$1,120
Genentech USA, Inc.
$777
GENZYME CORPORATION
$704
GlaxoSmithKline, LLC.
$559
Horizon Therapeutics plc
$267
Mallinckrodt LLC
$256
Aurinia Pharma U.S., Inc.
$208
Mallinckrodt Enterprises LLC
$204
Alexion Pharmaceuticals, Inc.
$168
Horizon Pharma plc
$143
SANOFI-AVENTIS U.S. LLC
$120
Organon Llc
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Radius Health, Inc.
$103
Organon LLC
$103
Zyla Life Sciences
$101
NOVARTIS PHARMACEUTICALS CORPORATION
$91
Octapharma USA, Inc.
$80
Takeda Pharmaceuticals U.S.A., Inc.
$80
Bioventus LLC
$75
Kyowa Kirin, Inc.
$53
Sobi, Inc
$50
SOBI, INC
$45
MEDAC PHARMA, INC.
$32
GRT US Holding, Inc.
$29
Medtronic, Inc.
$26
Cumberland Pharmaceuticals, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$23
HOSPIRA, INC.
$22
Mylan Institutional Inc.
$21
Teva Pharmaceuticals USA, Inc.
$17
DePuy Synthes Sales Inc.
$17
Biocon Biologics Inc
$16
Merck Sharp & Dohme Corporation
$16
Ironwood Pharmaceuticals, Inc
$14
Ultragenyx Pharmaceutical Inc.
$14
Gilead Sciences, Inc.
$13
MEDEXUS PHARMA, INC.
$13
Top 3 companies account for 70.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUPIXENT · DUROLANE · DUZALLO · Durolane · EVENITY · EVUSHELD · Enbrel · FLECTOR · FORTEO · HADLIMA · HUMIRA · HYQVIA · Hulio · Humira · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · MOVANTIK · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PANZYGA · PAXLOVID · PENNSAID · Prolia · Qutenza · RAYOS · REDITREX · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Trintellix · Truxima · Tymlos · ULTOMIRIS · Uloric · VENASEAL · VIMOVO · XELJANZ · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for optician in TX.

Equivalent to $485 per 100 Medicare services performed
Looking for a optician in Sugar Land?
Compare opticians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
413
Per 100K population
48.0
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hernandez is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 2%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hernandez experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hernandez performed 27,201 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hernandez receive payments from pharmaceutical companies?
Yes. Dr. Hernandez received a total of $251,006 from 50 companies across 1,540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hernandez's costs compare to other opticians in Sugar Land?
Dr. Hernandez's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hernandez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →